Skip to main content
logo
Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
16.93
+0.12 (0.71%)
At close: May 4, 2026, 4:00 PM EDT
16.75
-0.18 (-1.06%)
After-hours: May 4, 2026, 7:23 PM EDT

Nurix Therapeutics Revenue

Nurix Therapeutics had revenue of $6.25M in the quarter ending February 28, 2026, a decrease of -66.12%. This brings the company's revenue in the last twelve months to $71.78M, up 27.23% year-over-year. In the fiscal year ending November 30, 2025, Nurix Therapeutics had annual revenue of $83.98M with 53.95% growth.

Revenue (ttm)
$71.78M
Revenue Growth
+27.23%
P/S Ratio
24.39
Revenue / Employee
$226,432
Employees
317
Market Cap
1.75B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Nov 30, 202583.98M29.43M53.95%
Nov 30, 202454.55M-22.44M-29.15%
Nov 30, 202376.99M38.36M99.31%
Nov 30, 202238.63M8.88M29.84%
Nov 30, 202129.75M11.93M66.95%
Nov 30, 202017.82M-13.30M-42.73%
Nov 30, 201931.12M-6.33M-16.91%
Nov 30, 201837.45M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ardelyx427.68M
Innoviva411.33M
Vericel276.26M
Syndax Pharmaceuticals217.17M
Recursion Pharmaceuticals74.68M
Agios Pharmaceuticals66.05M
Generate Biomedicines31.89M
Capricor Therapeutics11.13M
Revenue Rankings

NRIX News

More News